skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
AAV9‐mediated AIRE gene delivery clears circulating antibodies and tissue T‐cell infiltration in a mouse model of autoimmune polyglandular syndrome type‐1
Material Type:
Article
Add to My Research

AAV9‐mediated AIRE gene delivery clears circulating antibodies and tissue T‐cell infiltration in a mouse model of autoimmune polyglandular syndrome type‐1

Clinical & translational immunology, 2020, Vol.9 (9), p.e1166-n/a [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1166 ;PMID: 32994995

Full text available

2
Accumulation of IL‐17+ Vγ6+ γδ T cells in pregnant mice is not associated with spontaneous abortion
Material Type:
Article
Add to My Research

Accumulation of IL‐17+ Vγ6+ γδ T cells in pregnant mice is not associated with spontaneous abortion

Clinical & translational immunology, 2018, Vol.7 (1), p.e1008-n/a [Peer Reviewed Journal]

2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australasian Society for Immunology Inc. ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1008 ;PMID: 29484185

Full text available

3
Activity of the growth hormone‐releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis‐like granuloma
Material Type:
Article
Add to My Research

Activity of the growth hormone‐releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis‐like granuloma

Clinical & translational immunology, 2021, Vol.10 (7), p.e1310-n/a [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc ;2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1310 ;PMID: 34257968

Full text available

4
Adaptive immunity to human coronaviruses is widespread but low in magnitude
Material Type:
Article
Add to My Research

Adaptive immunity to human coronaviruses is widespread but low in magnitude

Clinical & translational immunology, 2021, Vol.10 (3), p.e1264-n/a [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. ;2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1264 ;PMID: 33747512

Full text available

5
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis
Material Type:
Article
Add to My Research

Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis

Clinical & translational immunology, 2023, Vol.12 (4), p.e1446-n/a [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2023 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1446 ;PMID: 37091327

Full text available

6
Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non‐targeted tumour epitopes
Material Type:
Article
Add to My Research

Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non‐targeted tumour epitopes

Clinical & translational immunology, 2017-10, Vol.6 (10), p.e160-n/a [Peer Reviewed Journal]

2017 The Authors ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2017 The Author(s) 2017 The Author(s) ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1038/cti.2017.37 ;PMID: 29114389

Full text available

7
Adoptive T‐cell immunotherapy for ganciclovir‐resistant CMV disease after lung transplantation
Material Type:
Article
Add to My Research

Adoptive T‐cell immunotherapy for ganciclovir‐resistant CMV disease after lung transplantation

Clinical & translational immunology, 2015-03, Vol.4 (3), p.e35-n/a [Peer Reviewed Journal]

2015 The Authors ;2015. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2015 Australasian Society for Immunology Inc. 2015 Australasian Society for Immunology Inc. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1038/cti.2015.5 ;PMID: 25859390

Full text available

8
Altered regulatory T‐cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis
Material Type:
Article
Add to My Research

Altered regulatory T‐cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis

Clinical & translational immunology, 2017-05, Vol.6 (5), p.e143-n/a [Peer Reviewed Journal]

2017 The Authors ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2017 The Author(s) 2017 The Author(s) ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1038/cti.2017.18 ;PMID: 28690849

Full text available

9
An acetate‐yielding diet imprints an immune and anti‐microbial programme against enteric infection
Material Type:
Article
Add to My Research

An acetate‐yielding diet imprints an immune and anti‐microbial programme against enteric infection

Clinical & translational immunology, 2021, Vol.10 (1), p.e1233-n/a [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1233 ;PMID: 33489123

Full text available

10
An autologous colonic organoid‐derived monolayer model to study immune: bacterial interactions in Crohn's disease patients
Material Type:
Article
Add to My Research

An autologous colonic organoid‐derived monolayer model to study immune: bacterial interactions in Crohn's disease patients

Clinical & translational immunology, 2022, Vol.11 (8), p.e1407-n/a [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1407 ;PMID: 35924188

Full text available

11
Analysis of serum B cell‐activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus
Material Type:
Article
Add to My Research

Analysis of serum B cell‐activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus

Clinical & translational immunology, 2019, Vol.8 (4), p.e01047-n/a [Peer Reviewed Journal]

2019 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1047 ;PMID: 31024730

Full text available

12
Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis
Material Type:
Article
Add to My Research

Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis

Clinical & translational immunology, 2019, Vol.8 (4), p.e1045-n/a [Peer Reviewed Journal]

2019 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australasian Society for Immunology Inc. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1045 ;PMID: 30997045

Full text available

13
Analysis of serum macrophage migration inhibitory factor and D‐dopachrome tautomerase in systemic sclerosis
Material Type:
Article
Add to My Research

Analysis of serum macrophage migration inhibitory factor and D‐dopachrome tautomerase in systemic sclerosis

Clinical & translational immunology, 2018, Vol.7 (12), p.e1042-n/a [Peer Reviewed Journal]

2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australasian Society for Immunology Inc. ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1042 ;PMID: 30546906

Full text available

14
Analysis of the cross‐talk of Epstein–Barr virus‐infected B cells with T cells in the marmoset
Material Type:
Article
Add to My Research

Analysis of the cross‐talk of Epstein–Barr virus‐infected B cells with T cells in the marmoset

Clinical & translational immunology, 2017-02, Vol.6 (2), p.e127-n/a [Peer Reviewed Journal]

2017 The Authors ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2017 The Author(s) 2017 The Author(s) ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1038/cti.2017.1 ;PMID: 28243437

Full text available

15
Anti‐C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154‐mediated inflammation in peripheral blood mononuclear cells in vitro
Material Type:
Article
Add to My Research

Anti‐C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154‐mediated inflammation in peripheral blood mononuclear cells in vitro

Clinical & translational immunology, 2022, Vol.11 (8), p.e1408-n/a [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1408 ;PMID: 35928801

Full text available

16
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
Material Type:
Article
Add to My Research

Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients

Clinical & Translational Immunology, 2021, Vol.10 (8), p.e1327-n/a [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc ;2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1327 ;PMID: 34429968

Digital Resources/Online E-Resources

17
Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2
Material Type:
Article
Add to My Research

Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2

Clinical & Translational Immunology, 2021, Vol.10 (3), p.e1260-n/a [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1260 ;PMID: 33732459

Digital Resources/Online E-Resources

18
Antibody glycosylation correlates with disease progression in SIV- Mycobacterium tuberculosis coinfected cynomolgus macaques
Material Type:
Article
Add to My Research

Antibody glycosylation correlates with disease progression in SIV- Mycobacterium tuberculosis coinfected cynomolgus macaques

Clinical & translational immunology, 2023, Vol.12 (11), p.e1474-e1474 [Peer Reviewed Journal]

2023 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1474 ;PMID: 38020728

Full text available

19
Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
Material Type:
Article
Add to My Research

Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)

Clinical & Translational Immunology, 2020, Vol.9 (9), p.e1182-n/a [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1182 ;PMID: 33005417

Digital Resources/Online E-Resources

20
Associations of pathogen‐specific and host‐specific characteristics with disease outcome in patients with Staphylococcus aureus bacteremic pneumonia
Material Type:
Article
Add to My Research

Associations of pathogen‐specific and host‐specific characteristics with disease outcome in patients with Staphylococcus aureus bacteremic pneumonia

Clinical & translational immunology, 2019, Vol.8 (7), p.e01070-n/a [Peer Reviewed Journal]

2019 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. ;Copyright John Wiley & Sons, Inc. 2019 ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1070 ;PMID: 31360464

Full text available

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait